Pfizer Asks FDA to Authorize Its COVID Vaccine for Children Ages 5 to 11
Pfizer and its German partner BioNTech said Thursday they have made a formal request to the FDA to extend emergency use of its COVID-19 vaccine in children ages 5 to 11. Janelle Wang talks to UCSF’s Infectious Disease Expert Dr. Peter Chin-Hong on this.